Satori Pharmaceuticals makes appointments
This article was originally published in Scrip
Executive Summary
Satori Pharmaceuticals (US), a company focused on the development of disease-modifying therapies for Alzheimer's disease, has appointed Steven Holtzman as chair of its board of directors and Jeff Jonker as chief business officer. Mr Holtzman, executive chair and co-founder of Infinity Pharmaceuticals, recently joined Satori's board, while Mr Jonker was most recently vice-president of business development and strategic planning at Gloucester Pharmaceuticals.